510(k) Report

510(k) · Cleared

Cleared

MoMe Software Platform

K152491510(k) TraditionalCleared Dec 17, 2015107-day reviewClass II21 CFR 870.1025

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Infobionic, Inc. · DSI Detector And Alarm, Arrhythmia

Cleared on Dec 17, 2015 as substantially equivalent to K133753 (Infobionic, Inc., 2014) after a 107-day review. Its family tree reaches back 8 generations to 1997.

Decided
Dec 17, 2015
Review
107 days
Class
Class II
Product code
DSI
Recalls
None
Predicates
1

Its longest line of descent runs back 8 generations to K963725 (1997). 32 ancestors in all, the oldest K843503 (1984). No later device cites it as a predicate yet.

  1. Root · 8 generations backK963725 Model CG-2206 Personal Electrocardiogram (Ecg) Transmitter Device…Card Guard, Ltd. · 1997
  2. 7 generations backK012223 CG-2211 Selfcheck Ecg TransmitterCard Guard Scientific Survival, Ltd. · 2001
  3. 6 generations backK042254 PMP4 Selfcheck EcgCard Guard Scientific Survival, Ltd. · 2005
  4. 5 generations backK060911 CG-6108 Arrhythmia Ecg Event RecorderCard Guard Scientific Survival, Ltd. · 2006
  5. 4 generations backK071995 CG-6108 Continuous Ecg Monitor and Arrhythmia DetectorCard Guard Scientific Survival, Ltd. · 2007 · Recalled
  6. 3 generations backK081257 CG-6108 Act-3L Continuous Ecg Monitor & Arrhythmia DetectorCard Guard Scientific Survival, Ltd. · 2008 · Recalled
  7. 2 generations backK093288 Cardionet Ambulatory Ecg Monitor with Arrhythmia DetectionCardionet, Inc. · 2010
  8. 1 generation backK133753 Mome Ecg Continuous Detection and Arrhythmia DetectorInfobionic, Inc. · 2014
  9. This deviceK152491 MoMe Software PlatformInfobionic, Inc. · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K963725Model CG-2206 Personal Electrocardiogram (Ecg) Transmitter Device (Modified)Card Guard, Ltd.1997—
−7K012223CG-2211 Selfcheck Ecg TransmitterCard Guard Scientific Survival, Ltd.2001—
−6K042254PMP4 Selfcheck EcgCard Guard Scientific Survival, Ltd.2005—
−5K060911CG-6108 Arrhythmia Ecg Event RecorderCard Guard Scientific Survival, Ltd.2006—
−4K071995CG-6108 Continuous Ecg Monitor and Arrhythmia DetectorCard Guard Scientific Survival, Ltd.20072
−3K081257CG-6108 Act-3L Continuous Ecg Monitor & Arrhythmia DetectorCard Guard Scientific Survival, Ltd.20082
−2K093288Cardionet Ambulatory Ecg Monitor with Arrhythmia DetectionCardionet, Inc.2010—
−1K133753Mome Ecg Continuous Detection and Arrhythmia DetectorInfobionic, Inc.2014—
0 (this device)K152491MoMe Software PlatformInfobionic, Inc.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198410
198830
199210
199510
199610
199710
199810
199920
200010
200120
200210
200310
200410
200520
200620
200710
200910
201210
FIG. 1 — Lineage of K152491, 1997–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DSI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DSI device

  1. #1 K243349 BodyGuardian Remote Monitoring System (BGRMS…score 13.1 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K133753Mome Ecg Continuous Detection and Arrhythmia Detector
Summary page 4
…Common Name: Arrhythmia Detector and Alarm Classification Name: 21 CFR 870.1025, DSI Predicate Device: MoMe™ ECG Continuous Detection and Arrhythmia Detector, K133753 Device Description: MoMe® Software Platform is a cloud based arrhythmia analysis and ECG management software system used for A…
Infobionic, Inc.2014—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 4 companies; a new generation was cleared every 1.9 years on median.
  • 2 of the 32 ancestors have a recall of any class.

How does its category compare?

All DSI devices

DSI Detector And Alarm, Arrhythmia: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · DSI

1in 2025

2007: 72008: 52009: 62010: 62011: 62012: 32013: 12014: 42015: 92016: 62018: 22019: 32020: 22023: 22024: 12025: 12026 (partial year): 1
2007high 9 (2015) · low 0 (2017)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DSI

243in 2019

2007: 151 days median2008: 70 days median2009: 73 days median2010: 111 days median2011: 114 days median2012: 113 days median2014: 200 days median2015: 127 days median2016: 224 days median2019: 243 days median
2007high 243 (2019) · low 70 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DSI

18in 2025

2007: 42008: 82009: 32010: 52011: 32012: 12018: 12019: 42020: 22022: 12023: 22025: 182026 (partial year): 1
2007high 18 (2025) · low 0 (2013)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DSI

712in 2025

2007: 642008: 1562009: 2792010: 8232011: 7932012: 7662013: 7952014: 1,0002015: 1,6452016: 4,3522017: 3,5942018: 3,6482019: 3,4852020: 3,0842021: 3,0922022: 1,6382023: 1,6162024: 1,3202025: 712
2007high 4,352 (2016) · low 64 (2007)2025

MAUDE reports naming product code DSI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20077151464
20085708156
20096733279
201061115823
201161143793
201231131766
20131—0795
2014420001,000
2015912701,645
2016622404,352
20170—03,594
20182—13,648
2019324343,485
20202—23,084
20210—03,092
20220—11,638
20232—21,616
20241—01,320
20251—18712
20261—1—

What is it indicated for?

The MoMe® Software Platform is intended to be used for patients 22 years and older that have one or more of the following conditions: 1. Patients who have demonstrated a need for cardiac monitoring and are at low risk of developing primary ventricular fibrillation or sustained ventricular tachycardia 2. Patients with dizziness or lightheadedness. 3. Patients with palpitations. 4. Patients with syncope of unknown etiology. 5. Patients who require…

Read the full statement (194 words)

The MoMe® Software Platform is intended to be used for patients 22 years and older that have one or more of the following conditions:

1. Patients who have demonstrated a need for cardiac monitoring and are at low risk of developing primary ventricular fibrillation or sustained ventricular tachycardia

2. Patients with dizziness or lightheadedness.

3. Patients with palpitations.

4. Patients with syncope of unknown etiology.

5. Patients who require monitoring for non‐life threatening arrhythmias, such as atrial fibrillation, other supraventricular arrhythmias, evaluation of various bradyarrhythmias and intermittent bundle branch block.

6. Patients recovering from coronary artery bypass graft (CABG) surgery who require monitoring for arrhythmias.

7. Patients requiring monitoring for arrhythmias inducing co‐morbid conditions such as hyperthyroidism or chronic lung disease.

8. Patients with obstructive sleep apnea to evaluate possible nocturnal arrhythmias.

9. Patients requiring arrhythmia evaluation for etiology of stroke or transient cerebral ischemia, possibly secondary to atrial fibrillation.

The MoMe® Software Platform is contraindicated for:

1. Patients with potentially life threatening arrhythmias who require in-patient monitoring.

2. Patients who the attending physician thinks should be hospitalized.

3. Patients with implanted pacemakers, ICDs, neurostimulators and/or body worn medical devices such as insulin pumps.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K152491: MoMe Software Platform.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K152491

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026